Latest Articles

Approach for Patients with PAD and T2D: Focus on LDL-C Control

ACC/AHA vs ESC/EAS LDL–C recommendations for residual risk reduction in ASCVD: A simulation study from Da Vinci

Relationship Between LDL-C LLTs and Risk of Stroke

Lipid-Lowering Therapy and Achievement of Lipid Targets ESC and EAS Guidelines

LDL-C The Only Causal Risk Factor for ASCVD

Why low-density lipoprotein-cholesterol, the only causal risk factor for atherosclerotic cardiovascular disease, is still overlooked and underestimated.

LDL-C Targets in Patients with Heterozygous Familial Hypercholesterolemia

LLTs Exposure Time and Major Vascular Risk Reduction

PCSK9i after hospital discharge for acute MI

LLTs and Antithrombotic Therapy in PAD